IBD: Co-medication does not affect Results of Approval Studies

被引：0
|
作者：
Klein, Friederike
机构：
来源：
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2025年 / 63卷 / 02期
关键词：
D O I：
10.1055/a-2447-9225
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
In clinical Studies on Biologics or low-molecular-weight Active Substances, Participants with chronic inflammatory Bowel Disease (IBD) often receive other Drug Therapy in parallel with the Study Medication. An international Research Team with Lead Author Dhruv Ahuja from the Medical Clinic of the Indira Gandhi Hospital in New Delhi, India, examined whether this Concomitant Medication had an Influence on the Study Results
引用
收藏
页码：110 / 110
页数：1
相关论文
共 50 条
  • [41] How Does IBD Affect Quality of Life?
    Clearfield, Harris R.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 : S45 - S46
  • [42] Protracted Episode of Reduced Consciousness Following Co-Medication with Omeprazole and Clorazepate
    Achim Konrad
    Clinical Drug Investigation, 2000, 19 : 307 - 311
  • [43] Increase in plasma concentrations of amisulpricle after receiving co-medication with lithium
    Bergemann, N
    Kress, KR
    Abu-Tair, F
    Frick, A
    Kopitz, J
    PHARMACOPSYCHIATRY, 2005, 38 (01) : 44 - 44
  • [44] The Role of Conventional DMARDs Co-medication in TNF Inhibitor Drug Survival
    Kwan, Andrew
    Chow, Jocelyn
    Shah, Alpesh
    Soucy, Elaine
    Chow, Andrew
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 908 - 909
  • [45] Serum concentrations of levetiracetam in epileptic patients:: The influence of dose and co-medication
    May, TW
    Rambeck, B
    Jürgens, U
    THERAPEUTIC DRUG MONITORING, 2003, 25 (06) : 690 - 699
  • [46] Co-medication and polypharmacy with ADHD medications in adults: a Swedish nationwide study
    Zhang, L.
    Reif, A.
    Du Rietz, E.
    Lagerberg, T.
    Butwicka, A.
    D'Onofrio, B. M.
    Johnell, K.
    Pedersen, N. L.
    Larsson, H.
    Chang, Z.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S28 - S29
  • [47] Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin
    Haertter, Sebastian
    Koenen-Bergmann, Michael
    Sharma, Ashish
    Nehmiz, Gerhard
    Lemke, Ute
    Timmer, Wolfgang
    Reilly, Paul A.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (03) : 490 - 500
  • [48] Risk Factors for Co-Medication of Contraindicated Drugs in Hospitalized Elderly Patient
    Ahn, Eun Kyoung
    Park, Rae Woong
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 77 - 77
  • [49] Psychotropic co-medication among stimulant-treated children in The Netherlands
    Faber, A
    de Jong-van den Berg, LTW
    van den Berg, PB
    Tobi, H
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2005, 15 (01) : 38 - 43
  • [50] DOES CO-MEDICATION WITH CSDMARDS HAVE AN IMPACT ON THE RETENTION OF BDMARDS IN PSORIATIC SPONDYLOARTHRITIS? DATA FROM BIORX.SI
    Rotar, Z.
    Hocevar, A.
    Praprotnik, S.
    Tomsic, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 611 - 611
12345